These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 15735770)

  • 1. [Coronary stenting--a success history].
    Santos R
    Rev Port Cir Cardiotorac Vasc; 2004; 11(4):195-200. PubMed ID: 15735770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the drug-eluting stent trials.
    Coolong A; Kuntz RE
    Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous coronary intervention in New Zealand.
    Williams M
    N Z Med J; 2007 Jan; 120(1248):U2398. PubMed ID: 17277814
    [No Abstract]   [Full Text] [Related]  

  • 4. Bifurcation stenting: current strategies and new devices.
    Latib A; Colombo A; Sangiorgi GM
    Heart; 2009 Mar; 95(6):495-504. PubMed ID: 18812408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-eluting stents: efficacy, effectiveness, efficiency and evidence].
    Lázaro y de Mercado P
    Rev Esp Cardiol; 2004 Jul; 57(7):608-12. PubMed ID: 15274844
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of restenosis after coronary stenting, problem soon resolved].
    Kivelä A; Hartikainen J
    Duodecim; 2005; 121(11):1227-36. PubMed ID: 15999982
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of restenosis: is angioplasty the answer?
    Scheller B; Speck U; Böhm M
    Heart; 2007 May; 93(5):539-41. PubMed ID: 17435062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there any place for oral anti-restenotic treatment in the era of drug eluting stents?
    Gershlick AH
    Heart; 2005 Nov; 91(11):1377-9. PubMed ID: 16230428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
    Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
    Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting stents: a pharmacoclinical perspective.
    Thomas MK; Gupta YK
    Natl Med J India; 2006; 19(4):195-9. PubMed ID: 17100106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous stenting of the left main with drug eluting stents for in-stent restenosis: immediate- and long-term results.
    Mixon T; Fitzsimmons P
    J Invasive Cardiol; 2006 Jun; 18(6):E166-8. PubMed ID: 16775892
    [No Abstract]   [Full Text] [Related]  

  • 12. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era: a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR).
    Huang HW; Brent BN; Shaw RE
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):867-72. PubMed ID: 17080468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short and long-term outcomes of two drug eluting stents in bifurcation lesions.
    Chen JL; Gao RL; Yang YJ; Qiao SB; Qin XW; Yao M; Xu B; Liu HB; Wu YJ; Yuan JQ; Chen J; Wu Y; Dai J
    Chin Med J (Engl); 2007 Feb; 120(3):183-6. PubMed ID: 17355818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bifurcation intervention: is it crush time yet?
    Williams DO; Abbott JD
    J Am Coll Cardiol; 2005 Aug; 46(4):621-4. PubMed ID: 16098425
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-eluting stents in bifurcation lesions: to stent one branch or both?
    Assali AR; Assa HV; Ben-Dor I; Teplitsky I; Solodky A; Brosh D; Fuchs S; Kornowski R
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):891-6. PubMed ID: 17086532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Unprotected left main coronary artery stenting: immediate and medium-term outcomes of 24 procedures].
    Puymirat E; Labèque JN; Coste P
    Ann Cardiol Angeiol (Paris); 2008 Aug; 57(4):195-200. PubMed ID: 18550024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of patients with in-stent restenosis.
    Alfonso F; Pérez-Vizcayno MJ; Cruz A; García J; Jimenez-Quevedo P; Escaned J; Hernandez R
    EuroIntervention; 2009 May; 5 Suppl D():D70-8. PubMed ID: 19736076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous treatment of coronary bifurcation lesions: a novel "extended Y" technique with complete lesion stent coverage.
    Helqvist S; Jørgensen E; Kelbaek H; Aljabbari S; Thuesen L; Flensted Lassen J; Saunamäki K
    Heart; 2006 Jul; 92(7):981-2. PubMed ID: 16775110
    [No Abstract]   [Full Text] [Related]  

  • 20. Are drug-eluting stents cost-effective? It depends on whom you ask.
    Ryan J; Cohen DJ
    Circulation; 2006 Oct; 114(16):1736-43; discussion 1744. PubMed ID: 17043177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.